Other studies further demonstrated that treatment of ovarian cancer cells with cisplatin or oxaliplatin in combination with DENSpm results in enhanced anti-proliferative effects via enhancing SSAT expression [208,209,215]. This evidence concerns the gene SAT1 and ovarian carcinoma.